SU2C, Partners Award $16.6 Million for Cancer Research

SU2C, Partners Award $16.6 Million for Cancer Research

Stand Up To Cancer (SU2C), in partnership with the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, has announced grants totaling $16.6 million to four research "Dream Teams" looking to cure cancers of the lung and pancreas using a radical new approach focused on "intercepting" cancers at very early stages.

The teams, two focused on cancers of the pancreas and two focused on cancers of the lung, include the SU2C-Lustgarten Foundation Pancreatic Cancer Interception Dream Team, which was awarded $7 million for a genetic screening project that will test the family members of two thousand people who already have pancreatic cancer for their own risk of developing it; the SU2C-Lustgarten Foundation Pancreatic Cancer Interception Translational Research Team, which will receive $2.6 million to test new and intensive preoperative treatments to allow more patients to achieve a complete resection (surgical removal) and eradicate micrometastatic disease; the SU2C-LUNGevity-American Lung Association Lung Cancer Interception Dream Team, which was awarded $5 million to develop diagnostic tools such as nasal swabs, blood tests, and radiological imaging,to confirm whether lung abnormalities found on chest imaging are benign lung disease or lung cancer; and the SU2C-LUNGevity-American Lung Association Lung Cancer Interception Translational Research Team, which will receive $2 million to develop Lung Cancer Interception Assay (LCIA) that can be used in conjunction with low-dose CT scans to examine circulating tumor cells and tumor DNA. With the new grants, SU2C has launched twenty-two research teams since 2009.

"The SU2C Cancer Interception initiative is focused on developing both the technologies needed to find cancer or pre-cancerous activity at its earlier possible juncture, and the treatments to stop its progression," said Phillip A. Sharp, institute professor at MIT's Koch Institute for Integrative Cancer Research, Nobel laureate, and chair of SU2C's Scientific Advisory Committee. "This could save many lives and avoid untold human suffering."

For more information about the four Dream Teams, see the SU2C website.